EA201201548A1 - Новые способы получения p2x7r антагонистов - Google Patents

Новые способы получения p2x7r антагонистов

Info

Publication number
EA201201548A1
EA201201548A1 EA201201548A EA201201548A EA201201548A1 EA 201201548 A1 EA201201548 A1 EA 201201548A1 EA 201201548 A EA201201548 A EA 201201548A EA 201201548 A EA201201548 A EA 201201548A EA 201201548 A1 EA201201548 A1 EA 201201548A1
Authority
EA
Eurasian Patent Office
Prior art keywords
new ways
p2x7r antagonists
p2x7r
antagonists
synthesis
Prior art date
Application number
EA201201548A
Other languages
English (en)
Inventor
Михаэль Бёс
Original Assignee
Эффектис Фармасьютиклз Аг
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Эффектис Фармасьютиклз Аг filed Critical Эффектис Фармасьютиклз Аг
Publication of EA201201548A1 publication Critical patent/EA201201548A1/ru

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/40—Nitrogen atoms, not forming part of a nitro radical, e.g. isatin semicarbazone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/14—Radicals substituted by nitrogen atoms, not forming part of a nitro radical

Abstract

Описаны новые способы синтеза N-замещенных индол-3-ил-алкиламидных соединений, которые действуют в качестве P2X7R антагонистов, причем указанные способы включают перегруппировку промежуточного оксима.
EA201201548A 2010-05-14 2011-03-04 Новые способы получения p2x7r антагонистов EA201201548A1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP10162812 2010-05-14
PCT/EP2011/053283 WO2011141194A1 (en) 2010-05-14 2011-03-04 Novel methods for the preparation of p2x7r antagonists

Publications (1)

Publication Number Publication Date
EA201201548A1 true EA201201548A1 (ru) 2013-05-30

Family

ID=43924014

Family Applications (1)

Application Number Title Priority Date Filing Date
EA201201548A EA201201548A1 (ru) 2010-05-14 2011-03-04 Новые способы получения p2x7r антагонистов

Country Status (13)

Country Link
US (1) US20130060047A1 (ru)
EP (2) EP2386541A1 (ru)
JP (1) JP2013526496A (ru)
CN (1) CN102858741A (ru)
AU (1) AU2011252351A1 (ru)
BR (1) BR112012028850A2 (ru)
CA (1) CA2799115A1 (ru)
EA (1) EA201201548A1 (ru)
IL (1) IL222948A0 (ru)
MX (1) MX2012013075A (ru)
SG (1) SG185400A1 (ru)
WO (1) WO2011141194A1 (ru)
ZA (1) ZA201209495B (ru)

Family Cites Families (59)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB832568A (en) * 1956-08-03 1960-04-13 Clin Byla Ets Heterocyclic compounds and production thereof
US2930798A (en) * 1956-08-03 1960-03-29 Clin Byla Ets 3-alkanoyl 1-tertiary-amino-alkyl indol oximes and production thereof
SE9704545D0 (sv) 1997-12-05 1997-12-05 Astra Pharma Prod Novel compounds
SE9704544D0 (sv) 1997-12-05 1997-12-05 Astra Pharma Prod Novel compounds
SE9704546D0 (sv) 1997-12-05 1997-12-05 Astra Pharma Prod Novel compounds
RU2254333C2 (ru) 1999-04-09 2005-06-20 Астразенека Аб Производные адамантана, способ их получения, фармацевтическая композиция на их основе и способы лечения
SE9901875D0 (sv) 1999-05-25 1999-05-25 Astra Pharma Prod Novel compounds
SE9904505D0 (sv) 1999-12-09 1999-12-09 Astra Pharma Prod Novel compounds
TWI258462B (en) 1999-12-17 2006-07-21 Astrazeneca Ab Adamantane derivative compounds, process for preparing the same and pharmaceutical composition comprising the same
SE9904652D0 (sv) 1999-12-17 1999-12-17 Astra Pharma Prod Novel Compounds
SE9904738D0 (sv) 1999-12-22 1999-12-22 Astra Pharma Prod Novel compounds
GB0013737D0 (en) 2000-06-07 2000-07-26 Astrazeneca Ab Novel compounds
PA8557501A1 (es) 2001-11-12 2003-06-30 Pfizer Prod Inc Benzamida, heteroarilamida y amidas inversas
WO2003042190A1 (en) 2001-11-12 2003-05-22 Pfizer Products Inc. N-alkyl-adamantyl derivatives as p2x7-receptor antagonists
SE0103836D0 (sv) 2001-11-16 2001-11-16 Astrazeneca Ab Novel compounds
AU2002359524A1 (en) 2001-11-30 2003-06-17 The Government Of The United States Of America, Represented By The Secretary, Department Of Health A P2x7 receptor antagonists
NZ533649A (en) 2001-12-21 2006-01-27 King Pharmaceuticals Res & Dev Tyrosyl derivatives and their use as P2X7 receptor modulators
SE0200920D0 (sv) 2002-03-25 2002-03-25 Astrazeneca Ab Novel compounds
MXPA05005146A (es) * 2002-11-15 2005-07-22 Tibotec Pharm Ltd Indolpiridinio sustituido como compuestos antiinfecciosos.
PA8591801A1 (es) 2002-12-31 2004-07-26 Pfizer Prod Inc Inhibidores benzamidicos del receptor p2x7.
CA2511189A1 (en) 2002-12-31 2004-07-15 Pfizer Products Inc. Benzamide inhibitors of the p2x7 receptor
SE0300480D0 (sv) 2003-02-21 2003-02-21 Astrazeneca Ab Novel compounds
WO2004099146A1 (en) 2003-05-12 2004-11-18 Pfizer Products Inc. Benzamide inhibitors of the p2x7 receptor
GB0312609D0 (en) 2003-06-02 2003-07-09 Astrazeneca Ab Novel compounds
GB0324498D0 (en) 2003-07-21 2003-11-26 Aventis Pharma Inc Heterocyclic compounds as P2X7 ion channel blockers
SE0302139D0 (sv) 2003-07-28 2003-07-28 Astrazeneca Ab Novel compounds
SE0302192D0 (sv) 2003-08-08 2003-08-08 Astrazeneca Ab Novel compounds
WO2005019182A1 (en) 2003-08-20 2005-03-03 Bayer Healthcare Ag Pyrazolylmethylbenzamide derivatives as p2xt-receptor antagonists
JP2007509180A (ja) 2003-10-21 2007-04-12 インスパイアー ファーマシューティカルズ，インコーポレイティド 疼痛を治療するための、非ヌクレオチド組成物および方法
JP2007535553A (ja) 2004-04-29 2007-12-06 アボット・ラボラトリーズ アミノ−テトラゾール類縁体および使用方法
EP1758911A1 (en) * 2004-05-17 2007-03-07 Tibotec Pharmaceuticals Ltd. 1-heterocyclyl-1,5-dihydro-pyrido[3,2-b]indol-2-ones
KR20070011588A (ko) * 2004-05-17 2007-01-24 티보텍 파마슈티칼즈 리미티드 치환된 1-페닐-1,5-디히드로-피리도-[3,2-ｂ]인돌-2-온 및다른 ｈｉｖ 억제제의 배합물
ATE481403T1 (de) * 2004-05-17 2010-10-15 Tibotec Pharm Ltd Substituierte 1-phenyl-1,5-dihydro-pyridoä3,2- büindol-2-on-derivate verwendbar als pharmazeutische antiinfektiva
BRPI0512781A (pt) 2004-06-29 2008-04-08 Pfizer Prod Inc método para preparação de derivados de 5-{4-(2-hidroxi-propil)-3,5-dioxo-4,5-diidro-3h-[1,2,4]tria zin-2-il}-benzamida através da desproteção dos precursores de protetores de hidroxila
WO2006003513A1 (en) 2004-06-29 2006-01-12 Pfizer Products Inc. Method for preparing 5-`4-(2-hydroxy-ethyl)-3,5-dioxo-4,5-dihydro-3h-`1,2,4!-triazin-2-yl!benzamide derivatives with p2x7 inhibiting activity by reaction of the derivative unsubstituted in 4-position of the triazine with an oxiran in the presence of a lewis acid
US7241776B2 (en) 2004-08-02 2007-07-10 Abbott Laboratories Cyanoamidine P2X7 antagonists for the treatment of pain
SA05260265A (ar) 2004-08-30 2005-12-03 استرازينيكا ايه بي مركبات جديدة
SE0402925D0 (sv) 2004-11-30 2004-11-30 Astrazeneca Ab Novel Compounds
EP1831174B1 (en) 2004-12-24 2011-03-02 AstraZeneca AB Amide derivatives
EP1844003A4 (en) 2005-01-27 2010-09-22 Astrazeneca Ab NEW BIAROMATIC COMPOUNDS AS INHIBITORS OF THE P2X7 RECEPTOR
US20060211739A1 (en) 2005-02-08 2006-09-21 Arturo Perez-Medrano Use of selective P2X7 receptor antagonists
US7402596B2 (en) 2005-03-24 2008-07-22 Renovis, Inc. Bicycloheteroaryl compounds as P2X7 modulators and uses thereof
WO2006110516A1 (en) 2005-04-11 2006-10-19 Abbott Laboratories Acylhydrazide p2x7 antagonists and uses thereof
EP1885376A1 (en) 2005-05-05 2008-02-13 Medicure International Inc. Inhibition of atp-mediated, p2x7 dependent pathways by pyridoxal-5-phosphaste and vitamin b6 related compounds
CA2625940A1 (en) 2005-08-29 2007-03-08 Irma Bernatchez-Lemaire Use of histogranin and histogranin-like compounds as inhibitors of p2x7 receptor function and as anti-arthritic agents
US20100022531A1 (en) 2005-09-01 2010-01-28 Renovis, Inc. Novel compounds as p2x7 modulators and uses thereof
WO2007056046A1 (en) 2005-11-07 2007-05-18 Abbott Laboratories P2x7 receptor antagonists and methods of use
WO2007056091A2 (en) 2005-11-09 2007-05-18 Abbott Laboratories 2-phenyl-2h-pyraz0le derivatives as p2x7 receptor antagonists and uses thereof
JP5306986B2 (ja) 2006-03-16 2013-10-02 エボテック （ユーエス） インコーポレイテッド Ｐ２ｘ７調節因子としてのビシクロへテロアリール化合物およびその使用
US8546579B2 (en) 2006-03-16 2013-10-01 Evotec (Us) Inc. Bicycloheteroaryl compounds as P2X7 modulators and uses thereof
CA2645652A1 (en) 2006-03-16 2007-09-27 Renovis, Inc. Bicycloheteroaryl compounds as p2x7 modulators and uses thereof
US20100184802A1 (en) 2006-03-16 2010-07-22 Kelly Michael G Bicycloheteroaryl Compounds as P2X7 Modulators and Uses Thereof
TWI464148B (zh) 2006-03-16 2014-12-11 Evotec Us Inc 作為ｐ２ｘ7調節劑之雙環雜芳基化合物與其用途
US20100298285A1 (en) 2006-03-16 2010-11-25 Kelly Michael G Biclycloheteroaryl Compounds as P2x7 Modulators and Uses Thereof
ATE489088T1 (de) 2006-06-06 2010-12-15 Glaxo Group Ltd N- (phenylmethyl) -2- (1h-pyrazol-4-yl) acetamid- derivate als p2x7-antagonisten zur behandlung von schmerzen, entzündungen und neurodegeneration
GB0611154D0 (en) 2006-06-06 2006-07-19 Glaxo Group Ltd Novel receptor antagonists and their methods of use
US20080076924A1 (en) 2006-06-30 2008-03-27 Patrick Betschmann Piperazines as P2X7 antagonists
MX2009000117A (es) 2006-07-06 2009-01-23 Glaxo Group Ltd N-fenilmetil-5-oxo-prolin-2-amidas sustituidas como antagonistas de receptores p2x7 y sus metodos de uso.
MX2011010810A (es) * 2009-04-14 2012-01-12 Affectis Pharmaceuticals Ag Nuevos antagonistas de p2x7r y su uso.

Also Published As

Publication number Publication date
ZA201209495B (en) 2013-08-28
US20130060047A1 (en) 2013-03-07
IL222948A0 (en) 2012-12-31
MX2012013075A (es) 2012-12-17
BR112012028850A2 (pt) 2015-09-15
EP2569281A1 (en) 2013-03-20
AU2011252351A1 (en) 2012-10-11
JP2013526496A (ja) 2013-06-24
CA2799115A1 (en) 2011-11-17
CN102858741A (zh) 2013-01-02
SG185400A1 (en) 2012-12-28
WO2011141194A1 (en) 2011-11-17
EP2386541A1 (en) 2011-11-16

Similar Documents

Publication Publication Date Title
PH12015500263A1 (en) New bicyclic derivatives
PH12014502697B1 (en) New diazaspirocycloalkane and azaspirocycloalkane
EA201990240A1 (ru) Новые трициклические соединения в качестве противораковых средств
ZA201503125B (en) One-pot method for the synthesis of cu-ssz-13, the compound obtained by the method and use thereof
UY34156A (es) Compuestos inhibidores de metaloenzimas
UA108101C2 (xx) Похідні n3-заміщених n1-сульфоніл-5-фторпіримідинонів
MA34091B1 (fr) Anticorps anti-cd40
MY181898A (en) Heterocyclic compounds and uses thereof
EA201491811A1 (ru) АНТИ-LgR5 АНТИТЕЛА И ИММУНОКОНЪЮГАТЫ
EA201290772A1 (ru) Новые формы ивабрадина гидрохлорида
UA110338C2 (en) Chemical compounds
TR201901886T4 (tr) DNA-PK inhibitörleri.
EA201691272A1 (ru) Тетрагидропиридопиразины в качестве модуляторов gpr6
UY33925A (es) Inhibidores tricíclicos de quinasas
MA34058B1 (fr) Formes de rifaximine, et leurs utilisations
EA201490567A1 (ru) Новые бициклические производные дигидрохинолин-2-она
UA113062C2 (xx) Похідні 5-фтор-4-іміно-3-(заміщеного)-3,4-дигідропіримідин-2(1h)ону
IN2015DN03029A (ru)
MX370253B (es) Composiciones de compuestos de jasmonato y métodos de uso de las mismas.
JO3154B1 (ar) عوامل مضادة لـ trpv4
EA201590552A1 (ru) Аминохинолины в качестве ингибиторов киназы
UA106889C2 (uk) Похідні n1-ацил-5-фторпіримідинону
UA107671C2 (en) N1-substityted-5-fluoro-2-oxopyrimidinone-1(2h)-carboxamide derivatives
UY33976A (es) Derivados de pirazolo-pirimidina.
IN2014KN01062A (ru)